Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
915.81
+29.18 (+3.29%)
Streaming Delayed Price
Updated: 2:33 PM EDT, Mar 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,550,910
Open
893.49
Bid (Size)
915.36 (80)
Ask (Size)
916.26 (40)
Prev. Close
886.63
Today's Range
892.14 - 924.14
52wk Range
623.78 - 1,133.95
Shares Outstanding
956,580,893
Dividend Yield
0.76%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Eli Lilly Expands Into Sleep Medicine With Centessa Buyout
↗
Today 10:48 EDT
Eli Lilly to acquire Centessa Pharmaceuticals for $6.3B. CNTA stock surges 45% as Lilly expands its neuroscience and sleep medicine pipeline.
Via
Benzinga
The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals
Today 9:42 EDT
Today, March 31, 2026, the biotechnology landscape has been fundamentally reshaped. Eli Lilly and Company (NYSE: LLY) has officially announced a definitive agreement to acquire Centessa Pharmaceuticals...
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
Performance
YTD
-15.2%
-15.2%
1 Month
-10.0%
-10.0%
3 Month
-15.1%
-15.1%
6 Month
+26.1%
+26.1%
1 Year
+10.9%
+10.9%
More News
Read More
The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience
Today 9:39 EDT
Via
Finterra
Topics
Economy
Intellectual Property
Eli Lilly & Co (NYSE:LLY): A Prime Dividend Growth Candidate Backed by Strong Profitability
↗
March 30, 2026
Via
Chartmill
Eli Lilly To Buy Centessa Pharma For Up To $7.8 Billion; Centessa Shares Skyrocket
↗
Today 9:25 EDT
Via
Investor's Business Daily
2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More
↗
Today 7:58 EDT
Via
The Motley Fool
Merck Just Made a Big Bet on a New Cancer Growth Engine
↗
Today 7:58 EDT
Via
MarketBeat
Stock Market Today, March 30: High Oil Prices Drive Risk-Off Sentiment, Nasdaq Falls 0.7%
↗
March 30, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Bonds
Economy
Eli Lilly's CEO Says This Could Be a Game Changer for Its Business
↗
March 30, 2026
Via
The Motley Fool
Nervous About the Market? 3 Vanguard ETFs That Were Made for Times Like These.
↗
March 30, 2026
Via
The Motley Fool
Topics
Bonds
ETFs
Economy
Prediction: Buying Pfizer Stock Today Could Set You Up for Life
↗
March 29, 2026
Via
The Motley Fool
Topics
Intellectual Property
Eli Lilly Secures $2.75 Billion Deal With Insilico Medicine To Bring AI-Developed Drugs To Global Market: Report
↗
March 29, 2026
Via
Benzinga
1 Reason This Biotech Stock Could Triple Before Year-End
↗
March 29, 2026
Via
The Motley Fool
1 Reason Eli Lilly Stock Is Still a Buy
↗
March 28, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly
March 27, 2026
Via
MarketMinute
Eli Lilly vs Novo Nordisk: Which Obesity Drug Stock Is the Better Buy?
↗
March 27, 2026
Via
The Motley Fool
Corporate Fortress: S&P 500 Defies Gravity with Fifth Consecutive Quarter of Double-Digit Growth
March 27, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Institutional Investors Are Selling One of Wall Street's Premier Trillion-Dollar Club Members (No, Not Nvidia!)
↗
March 27, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
1 Vanguard Index Fund to Buy Before It Soars 129%, According to a Wall Street Strategist
↗
March 27, 2026
Via
The Motley Fool
Topics
ETFs
Retirement
Stocks
Could Buying Eli Lilly Today Set You Up for Life?
↗
March 26, 2026
Via
The Motley Fool
Topics
Intellectual Property
Wave Life Sciences Shakes Biotech Sector with Breakthrough Obesity Data: A New Era for ‘Quality’ Weight Loss
March 26, 2026
Via
MarketMinute
Firing on All Cylinders: Eli Lilly (NYSE:LLY) Q4 Earnings Lead the Way
March 25, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)
March 25, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
The Steel-Walled Resurgence: How Foreign Capital and Policy Are Powering a New U.S. Industrial Golden Age
March 25, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Energy
The Strategic Renaissance: Why 2026 is the Year of the Takeover Tailwind
March 25, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Frequently Asked Questions
Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 915.81
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 03/31/26 02:33 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 876.05B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 876B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.